secwatch / observer
8-K filed November 6, 2023, 6:59 PM ET ticker MED CIK 0000910329
earnings confidence high sentiment negative materiality 0.85

Medifast Q3 revenue down 39.6% YoY to $235.9M; EPS $2.12 vs $3.27

MEDIFAST INC

2023-Q3 EPS reported $8.55 revenue$881,039,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MEDIFAST INC reported third quarter ended September 30, 2023 results: revenue Revenue of $235.9 million, net income Net income of $23.1 million, EPS Earnings per diluted share ("EPS") of $2.12.

Period
third quarter ended September 30, 2023
Revenue
Revenue of $235.9 million
Net income
Net income of $23.1 million
EPS
Earnings per diluted share ("EPS") of $2.12
Result
reported results
Exact text from the filing
Medifast Announces Third Quarter 2023 Financial Results November 6, 2023 BALTIMORE--(BUSINESS WIRE)-- Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTA VIA®, today reported results for the third quarter ended September 30, 2023. Third Quarter 2023 • Revenue of $235.9 million, with revenue per active earning Coach of $5,008 • Independent active earning OPTA VIA Coaches of 47,100 • Net income of $23.1 million • Earnings per diluted share ("EPS") of $2.12
View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

MEDIFAST INC filing history →

Source: SEC EDGAR
accession 0001628280-23-037043
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.